Maureen M. Achebe

1.2k total citations
9 papers, 352 citations indexed

About

Maureen M. Achebe is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Maureen M. Achebe has authored 9 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 8 papers in Genetics and 3 papers in Rheumatology. Recurrent topics in Maureen M. Achebe's work include Iron Metabolism and Disorders (9 papers), Hemoglobinopathies and Related Disorders (7 papers) and Erythropoietin and Anemia Treatment (3 papers). Maureen M. Achebe is often cited by papers focused on Iron Metabolism and Disorders (9 papers), Hemoglobinopathies and Related Disorders (7 papers) and Erythropoietin and Anemia Treatment (3 papers). Maureen M. Achebe collaborates with scholars based in United States, Germany and Israel. Maureen M. Achebe's co-authors include Anat Gafter‐Gvili, Michael Auerbach, Lars L. Thomsen, Richard J. Derman, John A. Glaspy, Eloy Roman, Manuel Modiano, David H. Henry, Sagar U. Nigwekar and Ravi Thadhani and has published in prestigious journals such as Blood, Scientific Reports and Journal of the American Society of Nephrology.

In The Last Decade

Maureen M. Achebe

9 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maureen M. Achebe United States 8 256 203 60 38 36 9 352
H. Thoumsin Belgium 11 122 0.5× 90 0.4× 81 1.4× 44 1.2× 23 0.6× 30 317
Jessica H. Boyd United States 11 369 1.4× 426 2.1× 84 1.4× 47 1.2× 22 0.6× 13 576
Mammen Puliyel United States 9 248 1.0× 246 1.2× 90 1.5× 8 0.2× 44 1.2× 22 441
Chi Le United States 5 137 0.5× 90 0.4× 24 0.4× 8 0.2× 37 1.0× 14 289
Alex Aregbesola Finland 10 95 0.4× 50 0.2× 37 0.6× 5 0.1× 38 1.1× 26 269
Ivan V. Chopey Ukraine 4 294 1.1× 168 0.8× 15 0.3× 28 0.7× 52 1.4× 10 385
Giselle Kidson‐Gerber Australia 8 103 0.4× 115 0.6× 48 0.8× 3 0.1× 19 0.5× 35 200
B. Wibaut France 10 228 0.9× 60 0.3× 78 1.3× 17 0.4× 4 0.1× 31 307
Anders Ole Agger Denmark 10 272 1.1× 191 0.9× 98 1.6× 3 0.1× 93 2.6× 15 503
Yuxia Wu China 7 83 0.3× 16 0.1× 73 1.2× 13 0.3× 3 0.1× 16 259

Countries citing papers authored by Maureen M. Achebe

Since Specialization
Citations

This map shows the geographic impact of Maureen M. Achebe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen M. Achebe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen M. Achebe more than expected).

Fields of papers citing papers by Maureen M. Achebe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen M. Achebe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen M. Achebe. The network helps show where Maureen M. Achebe may publish in the future.

Co-authorship network of co-authors of Maureen M. Achebe

This figure shows the co-authorship network connecting the top 25 collaborators of Maureen M. Achebe. A scholar is included among the top collaborators of Maureen M. Achebe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maureen M. Achebe. Maureen M. Achebe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kennedy, Nicholas A., et al.. (2023). A systematic literature review and meta-analysis of the incidence of serious or severe hypersensitivity reactions after administration of ferric derisomaltose or ferric carboxymaltose. International Journal of Clinical Pharmacy. 45(3). 604–612. 10 indexed citations
2.
Auerbach, Michael, Maureen M. Achebe, Lars L. Thomsen, & Richard J. Derman. (2022). Efficacy and safety of ferric derisomaltose (FDI) compared with iron sucrose (IS) in patients with iron deficiency anemia after bariatric surgery. Obesity Surgery. 32(3). 810–818. 7 indexed citations
3.
Kumar, Vivek, Neha Chaudhary, & Maureen M. Achebe. (2020). Epidemiology and Predictors of all-cause 30-Day readmission in patients with sickle cell crisis. Scientific Reports. 10(1). 2082–2082. 23 indexed citations
4.
Allegretti, Andrew S., Maureen M. Achebe, Nwamaka D. Eneanya, et al.. (2019). Kidney Function Decline among Black Patients with Sickle Cell Trait and Sickle Cell Disease: An Observational Cohort Study. Journal of the American Society of Nephrology. 31(2). 393–404. 33 indexed citations
5.
Eneanya, Nwamaka D., et al.. (2019). Cardiovascular Outcomes in African Americans with Sickle Cell Trait and Chronic Kidney Disease. American Journal of Nephrology. 49(2). 93–102. 5 indexed citations
6.
Auerbach, Michael, David H. Henry, Richard J. Derman, et al.. (2019). A prospective, multi‐center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON‐IDA trial. American Journal of Hematology. 94(9). 1007–1014. 63 indexed citations
7.
Eneanya, Nwamaka D., Sagar U. Nigwekar, Xavier Vela Parada, et al.. (2018). Sickle Cell Nephropathy in the Pediatric Population. Blood Purification. 47(1-3). 205–213. 24 indexed citations
8.
Derman, Richard J., Eloy Roman, Manuel Modiano, et al.. (2017). A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia. American Journal of Hematology. 92(3). 286–291. 67 indexed citations
9.
Achebe, Maureen M. & Anat Gafter‐Gvili. (2016). How I treat anemia in pregnancy: iron, cobalamin, and folate. Blood. 129(8). 940–949. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Thoumsin Breakdown of academic impact, for papers by Jessica H. Boyd Breakdown of academic impact, for papers by Mammen Puliyel Breakdown of academic impact, for papers by Chi Le Breakdown of academic impact, for papers by Alex Aregbesola Breakdown of academic impact, for papers by Ivan V. Chopey Breakdown of academic impact, for papers by Giselle Kidson‐Gerber Breakdown of academic impact, for papers by B. Wibaut Breakdown of academic impact, for papers by Anders Ole Agger Breakdown of academic impact, for papers by Yuxia Wu
Rankless by CCL
2026